Related Experiment Video
Updated: Jul 2, 2025
05:20
Development of a Rabbit Chronic-Like Rotator Cuff Injury Model for Study of Fibrosis and Muscular Fatty Degeneration
Published on: March 31, 2023
1.2K
Optimizing Tissue Engineering for Clinical Relevance in Rotator Cuff Repair.
Maxwell S Durtschi1, Sungwoo Kim2, Jiannan Li2
1Stanford University School of Medicine, Stanford, California, USA.
Tissue Engineering. Part B, Reviews
|February 27, 2024
Summary
Rotator cuff tears are common, leading to surgery with high retear rates. Tissue engineering with mesenchymal stem cells and growth factors shows promise for better healing and stronger repairs in animal models.
Area of Science:
- Orthopedics
- Regenerative Medicine
- Biomaterials Science
Background:
- Rotator cuff tears (RCT) are a leading cause of upper extremity disability, necessitating over 460,000 surgeries annually in the US.
- Postoperative complications, including retear and poor healing, occur frequently, with retear rates reported between 29.5% and 94%.
- Current grafts lack biological cues and fail to prevent scar tissue, contributing to surgical failure.
Purpose of the Study:
- To review the potential of tissue engineering strategies, specifically mesenchymal stem cells (MSCs) and growth factors (GFs), for improving rotator cuff enthesis repair.
- To bridge the gap between promising animal model findings and clinical applications for rotator cuff repair grafts.
Main Methods:
- Review of literature on tissue engineering approaches for rotator cuff repair.
- Analysis of studies demonstrating the efficacy of MSCs and GFs in enhancing enthesis regeneration and mechanical strength in animal models.
- Evaluation of different delivery methods for MSCs and GFs, including direct injection and incorporation into biomaterials.
Main Results:
- Animal models show MSCs and GFs significantly enhance native enthesis repair, leading to improved mechanical strength.
- MSCs and GFs promote beneficial biological processes like anti-inflammation, osteogenesis, angiogenesis, and chondrogenesis at the bone-tendon interface.
- Various delivery methods for MSCs and GFs have been explored, showing potential for clinical translation.
Conclusions:
- Mesenchymal stem cells and growth factors hold significant promise for enhancing rotator cuff enthesis regeneration and improving surgical outcomes.
- Future rotator cuff repair grafts should be designed for stable implantation, arthroscopic compatibility, and effective delivery of MSCs and/or GFs.
- Translating successful animal model findings into clinically applicable grafts is crucial for addressing the limitations of current rotator cuff repair techniques.
